Pathios Therapeutics

Pathios Therapeutics

UK - Abingdon
Biotechnology

Focus: Novel small-molecule modulators of GPR65

Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies

Oncology
Funding Stage
SERIES B
Open Jobs
0

Pipeline & Clinical Trials

Phase 1/2
Clinical Trials (1)
NCT06634849An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2017
Portfolio: 1 clinical trial
Top TAs: Oncology
Publications: 2 in PubMed
Therapeutic Area Focus
Oncology
1 pipeline
Marketed
Pipeline